Gregg Robert Patterson
Directeur Général chez Xlumena, Inc.
Profil
Mr. Gregg R.
Patterson is President, Chief Executive Officer & Director at Xlumena, Inc., Regional Vice President at 1832 Asset Management LP and Vice President-Sales & Distribution at Satiety, Inc. He is on the Board of Directors at Xlumena, Inc.
Mr. Patterson was previously employed as Vice President-International Sales by Acclarent, Inc.
He received his undergraduate degree from York University.
Postes actifs de Gregg Robert Patterson
| Sociétés | Poste | Début |
|---|---|---|
Xlumena, Inc.
 Xlumena, Inc. Medical SpecialtiesHealth Technology Xlumena, Inc. operates as a medical device company. The company was founded by Kenneth F. Binmoeller in 2004 and is headquartered in Mountain View, CA. | Directeur Général | 01/01/2011 |
Anciens postes connus de Gregg Robert Patterson
| Sociétés | Poste | Fin |
|---|---|---|
Acclarent, Inc.
 Acclarent, Inc. Medical SpecialtiesHealth Technology Acclarent, Inc. engages in manufacturing, designing, and commercializing medical devices that address conditions affecting the ear, nose, and throat. Its products include balloon sinuplasty, eustachian tube dilation, airway dilation system, and ethmoid punch. The company was founded by Joshua Makower and John Y. Chang in June 2004 and is headquartered in Irvine, CA. | Sales & Marketing | - |
Satiety, Inc.
 Satiety, Inc. Medical SpecialtiesHealth Technology Satiety, Inc. was a medical device manufacturing company. It produced and marketed less invasive devices for the treatment of obesity. The company was founded in 2000 through a collaboration of medical device incubators Thomas Fogarty Engineering and The Foundry and was headquartered in Palo Alto, CA. | Sales & Marketing | - |
1832 Asset Management LP
 1832 Asset Management LP Investment ManagersFinance 1832 Asset Management LP (1832 AM) is a Canadian asset management firm headquartered in Toronto, Ontario. The firm does business as Scotia Global Asset Management and is a subsidiary of Bank of Nova Scotia (NYSE, TSX: BNS). In 2013, another BNS subsidiary, GCIC Ltd. underwent an internal consolidation and transferred its asset management business to 1832 AM. In 2008, through a reorganization by the Bank of Nova Scotia, Scotia Asset Management came to encompass the Scotia Funds, the asset management programs that had been run by the bank's brokerage arm Scotia McLeod and Scotia Cassels Investment Counsel Ltd. 1832 AM offers a broad range of investment solutions to meet the diverse needs of clients across all levels of wealth in Canada and around the world. | Gestionnaire de Portefeuille-Actions | - |
Formation de Gregg Robert Patterson
| York University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
1832 Asset Management LP
1832 Asset Management LP Investment ManagersFinance 1832 Asset Management LP (1832 AM) is a Canadian asset management firm headquartered in Toronto, Ontario. The firm does business as Scotia Global Asset Management and is a subsidiary of Bank of Nova Scotia (NYSE, TSX: BNS). In 2013, another BNS subsidiary, GCIC Ltd. underwent an internal consolidation and transferred its asset management business to 1832 AM. In 2008, through a reorganization by the Bank of Nova Scotia, Scotia Asset Management came to encompass the Scotia Funds, the asset management programs that had been run by the bank's brokerage arm Scotia McLeod and Scotia Cassels Investment Counsel Ltd. 1832 AM offers a broad range of investment solutions to meet the diverse needs of clients across all levels of wealth in Canada and around the world. | Finance |
Acclarent, Inc.
Acclarent, Inc. Medical SpecialtiesHealth Technology Acclarent, Inc. engages in manufacturing, designing, and commercializing medical devices that address conditions affecting the ear, nose, and throat. Its products include balloon sinuplasty, eustachian tube dilation, airway dilation system, and ethmoid punch. The company was founded by Joshua Makower and John Y. Chang in June 2004 and is headquartered in Irvine, CA. | Health Technology |
Satiety, Inc.
Satiety, Inc. Medical SpecialtiesHealth Technology Satiety, Inc. was a medical device manufacturing company. It produced and marketed less invasive devices for the treatment of obesity. The company was founded in 2000 through a collaboration of medical device incubators Thomas Fogarty Engineering and The Foundry and was headquartered in Palo Alto, CA. | Health Technology |
Xlumena, Inc.
Xlumena, Inc. Medical SpecialtiesHealth Technology Xlumena, Inc. operates as a medical device company. The company was founded by Kenneth F. Binmoeller in 2004 and is headquartered in Mountain View, CA. | Health Technology |
